Glucocorticoids Do Not Cause Neutropenia—They Cause Neutrophilia
Glucocorticoid therapy consistently increases neutrophil counts, not decreases them. The mechanism involves demargination of neutrophils from vessel walls into circulation and prolonged neutrophil survival by inhibiting apoptosis 1. If a patient on steroids develops neutropenia, you must look for alternative causes—the steroids are not responsible.
Understanding the Steroid Effect on Neutrophils
Expected Neutrophil Response to Steroids
Glucocorticoids cause a predictable rise in neutrophil counts through two mechanisms:
- Demargination: Neutrophils shift from the marginated pool (adhered to vessel walls) into circulating blood
- Prolonged survival: Steroids inhibit neutrophil apoptosis, keeping cells alive longer 1
Magnitude of increase 2:
- Low-dose steroids: Mean increase of 0.3 × 10⁹/L
- Medium-dose steroids: Mean increase of 1.7 × 10⁹/L
- High-dose steroids: Mean increase of 4.84 × 10⁹/L
- Peak effect: Occurs at 48 hours after administration
In patients with acute infections, chronic steroid users show an average WBC increase of 5 × 10⁹/L compared to non-users 3. This effect is so consistent that observed neutrophilia in hospitalized patients is primarily associated with underlying disease rather than the glucocorticoid itself 4.
When Neutropenia Occurs Despite Steroids
If a patient on glucocorticoids develops neutropenia, the steroids are not the cause—investigate these alternative etiologies:
Primary causes to consider:
- Underlying disease process: The condition being treated may cause bone marrow suppression
- Concurrent medications: Chemotherapy, immunosuppressants, or other myelosuppressive drugs
- Infections: Severe sepsis can cause neutropenia despite steroid use 5
- Autoimmune destruction: Immune-mediated neutropenia (though paradoxically, steroids typically treat this) 6
- Bone marrow failure: Aplastic anemia, myelodysplasia, or marrow infiltration
Critical Clinical Pitfall
Do not attribute neutropenia to steroid therapy. This is a dangerous misinterpretation that can delay diagnosis of serious underlying conditions. The evidence consistently shows steroids increase neutrophil counts across all doses and durations 4, 2, 3.
Special Consideration: Steroid-Responsive Neutropenia
Paradoxically, high-dose steroids can treat certain neutropenic conditions 7, 8. In idiopathic chronic neutropenia and cyclical neutropenia, high-dose methylprednisolone has induced dramatic neutrophil recovery and bone marrow maturation. This further confirms that steroids promote rather than suppress neutrophil production.
Practical Approach to Neutropenia in a Steroid-Treated Patient
Step 1: Confirm true neutropenia (absolute neutrophil count <1500 cells/mm³, with severe neutropenia <500 cells/mm³) 9
Step 2: Review all concurrent medications for myelosuppressive agents
Step 3: Assess for infection—particularly in immunocompromised patients where steroids mask inflammatory signs 10
Step 4: Consider bone marrow evaluation if:
- Neutropenia is severe (<500 cells/mm³)
- Duration exceeds 10 days
- No obvious alternative cause identified
- Multiple cell lines affected
Step 5: In select cases of autoimmune neutropenia, increasing steroid dose may paradoxically improve neutrophil counts 6
Monitoring Considerations
For patients on prolonged glucocorticoid therapy (>3 months at >7.5 mg prednisone daily), monitor for steroid complications 11:
- Blood pressure and peripheral edema
- Blood glucose
- Body weight
- Lipid profile
However, routine neutrophil monitoring is not indicated for steroid-induced effects, as steroids elevate rather than suppress counts. Monitor neutrophils only if there is concern for bone marrow suppression from other causes.
Context for Specific Patient Populations
Neutropenic patients with cancer: Colony-stimulating factors (G-CSF) are recommended prophylactically to shorten neutropenia duration 12. Steroids do not interfere with this approach and may provide additional benefit through their anti-apoptotic effects on neutrophils.
Transplant recipients: High-dose glucocorticoids are standard immunosuppression 13. The expected neutrophilia from steroids should not be misinterpreted as infection, though infection risk remains elevated and requires vigilance 14.
Patients with refractory asthma: Neutrophilic inflammation may predominate in severe disease, and steroids can prolong neutrophil survival in airways 15. This is distinct from systemic neutropenia and represents local airway inflammation.